Clinical Trials Logo

Clinical Trial Summary

This randomized, placebo-controlled, double-blind study investigated the efficacy and safety of the herbal medicinal product containing a combination of extracts of restharrow root (Ononidis radix), Java tea (Orthosiphonis folium) and goldenrod herb (Solidaginis herba) in women with acute lower uUTI.


Clinical Trial Description

This randomized, placebo-controlled, double-blind study investigated the efficacy and safety of the herbal medicinal product containing a combination of extracts of restharrow root (Ononidis radix), Java tea (Orthosiphonis folium) and goldenrod herb (Solidaginis herba) in the treatment of acute lower uUTI. The herbal medicinal product represent a multi-target therapy that includes diuretic, anti-inflammatory and antimicrobial aspects.

Patients were randomized to one of the two treatment groups and treated with the phytotherapeutic agent or matching placebo for seven days.

The primary endpoint was microbiologic response defined as reduction in bacterial urine culture counts by at least 10*2 CFU/ml. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04032574
Study type Interventional
Source Medice Arzneimittel Pütter GmbH & Co KG
Contact
Status Completed
Phase Phase 3
Start date October 8, 1991
Completion date March 27, 1992

See also
  Status Clinical Trial Phase
Recruiting NCT05399797 - Management of Acute Uncomplicated UTIs in Adults by Community Pharmacists N/A
Recruiting NCT05667207 - Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI) N/A
Not yet recruiting NCT03658291 - Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection Phase 4